Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

PARP1 inhibition sensitizes AML to CD123 CAR-NK cells via immunophenotypic remodeling

Lea Kramer, Saskia Rudat, Shalini Ramachandran, Anna Stanger, Luca Hensen, Rimas Orentas, Congcong Zhang, Dominika Lukas, Fenja Gierschek, Evelyn Ullrich, Claudia Lengerke

Blood (2025) 146 (Supplement 1): 2357.

https://doi.org/10.1182/blood-2025-2357

Published: 2025

Journal Articles

Immune recovery and immunologic remodeling after CD19-directed chimeric antigen receptor T cell therapy in autoimmune diseases

Andreas Riedel, Ann-Christin Pecher, Lucca Kimmich, Dennis Usow, Luca Hensen, Jan Christian Schroeder, Saskia Rudat, Hildegard Keppeler, Jianfeng Liu, Christoph Faul, Anna Stanger, Wolfgang Bethge, Joerg Henes, Claudia Lengerke

Blood (2025) 146 (Supplement 1): 2335.

https://doi.org/10.1182/blood-2025-2335

Published: 2025

Journal Articles

CD19/CD22 CAR-T cells in adult patients with relapsed/refractory B-cell malignancies

Laurent Phely, Stefan Hug, Luca Hensen, Elena Mirovic, Christoph Faul, Wichard Vogel, Claudia Lengerke, Wolfgang Bethge

Blood (2025) 146 (Supplement 1): 4142.

https://doi.org/10.1182/blood-2025-4142

Published: 2025

Journal Articles

Defining a high-risk population for CAR-T-cell therapy: The impact of clonal hematopoiesis and pre-existing neutropenia on severe outcomes in patients treated for malignant and non-malignant conditions

Alisha Weiss-Haug, Reka Haraszti, Jan Christian Schroeder, Kristina Reuß, Britta Merz, Saskia Rudat, Hildegard Keppeler, Lea Kramer, Elena Mirovic, Christoph Faul, Ann-Christin Pecher, Joerg Henes, Katrin Lutz, Luca Hensen, Wolfgang Bethge, Friederike Schwartz, Claudia Lengerke

Blood (2025) 146 (Supplement 1): 5942.

https://doi.org/10.1182/blood-2025-5942

Published: 2025

Journal Articles

Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series

Stefan Hug, Laurent Phely, Andreas Riedel, Simon Killinger, Luca Hensen, Christoph Faul, Wolfgang Andreas Bethge, Claudia Lengerke

Blood (2024) 144 (Supplement 1): 6544.

https://doi.org/10.1182/blood-2024-200768

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

PARP1 inhibition sensitizes AML to CD123 CAR-NK cells via immunophenotypic remodeling

Immune recovery and immunologic remodeling after CD19-directed chimeric antigen receptor T cell therapy in autoimmune diseases

CD19/CD22 CAR-T cells in adult patients with relapsed/refractory B-cell malignancies

Defining a high-risk population for CAR-T-cell therapy: The impact of clonal hematopoiesis and pre-existing neutropenia on severe outcomes in patients treated for malignant and non-malignant conditions

Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series

Email alerts

ASH Publications

American Society of Hematology

Update search

PARP1 inhibition sensitizes AML to CD123 CAR-NK cells via immunophenotypic remodeling

Immune recovery and immunologic remodeling after CD19-directed chimeric antigen receptor T cell therapy in autoimmune diseases

CD19/CD22 CAR-T cells in adult patients with relapsed/refractory B-cell malignancies

Defining a high-risk population for CAR-T-cell therapy: The impact of clonal hematopoiesis and pre-existing neutropenia on severe outcomes in patients treated for malignant and non-malignant conditions

Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only